Likewise, high levels of HMGB1 are found in obese patients (Guzmán-Ruiz et al. 2021) and patients with type 2 diabetes (Wang et al. 2016), CVD, and IBD (Kang et al. 2014). Here, HMGB1 is linked to inflammatory bowel disease.